![](/img/cover-not-exists.png)
Preclinical evaluation of 131 I-Bevacizumab – A prospective agent for radioimmunotherapy in VEGF expressing cancers
Kameswaran, Mythili, Sarma, Haladhar Dev, Dash, AshutoshVolume:
123
Language:
english
Journal:
Applied Radiation and Isotopes
DOI:
10.1016/j.apradiso.2017.02.024
Date:
May, 2017
File:
PDF, 637 KB
english, 2017